Abbott Stock: Medical Giant Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott Stock: Medical Giant Shrugs Off ‘Middling’ Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott stock reversed early losses Wednesday, shrugging off a “middling” quarter, on its strong sales outlook for 2025 and a bullish fourth-quarter performance from its diabetes devices. ↑ X NOW PLAYING How To Buy Stocks: Profit From Earnings Reports Using This Option Strategy For the full year, Abbott Laboratories (ABT) expects sales to grow 7.5%…

Read More
Dow Jones Futures Fall; Nvidia Chipmaker Taiwan Semiconductor Lifts Techs| Investor's Business Daily

Dow Jones Futures Fall; Nvidia Chipmaker Taiwan Semiconductor Lifts Techs| Investor’s Business Daily

Dow Jones futures fell modestly early Thursday amid mixed UnitedHealth (UNH) results while S&P 500 futures and Nasdaq futures rose slightly as Nvidia chipmaker Taiwan Semiconductor (TSM) lifted techs. Bank of America (BAC) and Morgan Stanley (MS) topped views. The stock market rally had a strong Wednesday, fueled by a surprise drop in core CPI…

Read More